In accordance with the pleiotropic actions of leptin, emerging studies have evaluated the efficacy of leptin-based and LEPR antagonist therapy as anti-obesity approaches in the setting of both leptin sensitivity and resistance states. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.